Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MicroTech Medical (Hangzhou) CoHKSE:02235 +1.47%80 Piotroski F-Score is 6 as of Aug. 24, 2026, which is 50% above its 10-year median of 4.00. GuruFocus rates HKSE:02235 with a GF Score™ of 80/100 and a GF Value™ of HK$15.94 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 808 Medical Devices & Instruments companies, MicroTech Medical (Hangzhou) Co ranks better than 80.69% on this metric.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
MicroTech Medical (Hangzhou) Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.
The historical rank and industry rank for MicroTech Medical (Hangzhou) Co's Piotroski F-Score or its related term are showing as below:
HKSE:02235'
s Piotroski F-Score Range Over the Past 10 Years
Min: 2 Med: 4 Max: 6
Current: 6
During the past 7 years, the highest Piotroski F-Score of MicroTech Medical (Hangzhou) Co was 6. The lowest was 2. And the median was 4.
MicroTech Medical (Hangzhou) Co (HKSE:02235) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
MicroTech Medical (Hangzhou) Co Piotroski F-Score Related Terms
MicroTech Medical (Hangzhou) Co Piotroski F-Score Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MicroTech Medical (Hangzhou) Co Piotroski F-Score Chart
HKSE:02235 vs ABT, SYK, MDT: Piotroski F-Score Comparison
For the Medical Devices subindustry, MicroTech Medical (Hangzhou) Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MicroTech Medical (Hangzhou) Co Piotroski F-Score vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, MicroTech Medical (Hangzhou) Co's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where MicroTech Medical (Hangzhou) Co's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
MicroTech Medical (Hangzhou) Co's current Net Income (TTM) was 44.4.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
MicroTech Medical (Hangzhou) Co's current Cash Flow from Operations (TTM) was 36.0.
==> Positive ==> Score 1.
Question 3. Change in Return on Assets
Compare this year's return on assets (1) to last year's return on assets.
MicroTech Medical (Hangzhou) Co's return on assets of this year was 0.01935634. MicroTech Medical (Hangzhou) Co's return on assets of last year was -0.02853979.
==> This year is higher. ==> Score 1.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
MicroTech Medical (Hangzhou) Co's gearing of this year was 0.0001569. MicroTech Medical (Hangzhou) Co's gearing of last year was 0.
==> Last year is lower than this year ==> Score 0.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
MicroTech Medical (Hangzhou) Co's current ratio of this year was 6.38569287. MicroTech Medical (Hangzhou) Co's current ratio of last year was 11.41101647.
==> Last year's current ratio is higher ==> Score 0.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
MicroTech Medical (Hangzhou) Co's number of shares in issue this year was 413.932. MicroTech Medical (Hangzhou) Co's number of shares in issue last year was 420.788.
==> There is smaller number of shares in issue this year, or the same. ==> Score 1.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
MicroTech Medical (Hangzhou) Co's gross margin of this year was 0.54388476. MicroTech Medical (Hangzhou) Co's gross margin of last year was 0.52926899.
==> This year's gross margin is higher. ==> Score 1.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
MicroTech Medical (Hangzhou) Co's asset turnover of this year was 0.31432479. MicroTech Medical (Hangzhou) Co's asset turnover of last year was 0.15389776.
==> This year's asset turnover is higher. ==> Score 1.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
1
+
1
+
1
+
0
+
0
+
0
+
1
+
1
+
1
=
6
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
MicroTech Medical (Hangzhou) Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.
MicroTech Medical (Hangzhou) Co (HKSE:02235) has a Piotroski F-Score of 6 as of Aug. 24, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on MicroTech Medical (Hangzhou) Co and its competitors. This is 50% above median its historical median of 4.00. Over the past decade, MicroTech Medical (Hangzhou) Co's Piotroski F-Score has ranged from 2.00 to 6.00. According to the industry distribution chart, MicroTech Medical (Hangzhou) Co ranks #156 out of 808 companies in the Medical Devices & Instruments industry, placing it in the top 19.3%.
Is MicroTech Medical (Hangzhou) Co's Piotroski F-Score too high?
MicroTech Medical (Hangzhou) Co's current Piotroski F-Score of 6 is 50% above median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 6.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. MicroTech Medical (Hangzhou) Co's value of 6 is 20% above this industry median. Based on the distribution chart, MicroTech Medical (Hangzhou) Co ranks #156 out of 808 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, MicroTech Medical (Hangzhou) Co has a GF Score™ of 80/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MicroTech Medical (Hangzhou) Co's Piotroski F-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, MicroTech Medical (Hangzhou) Co ranks #156 out of 808 companies for Piotroski F-Score. This places MicroTech Medical (Hangzhou) Co in the top 19% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. MicroTech Medical (Hangzhou) Co's value of 6 is 20% above this benchmark. Historically, MicroTech Medical (Hangzhou) Co's own Piotroski F-Score has ranged from 2.00 to 6.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 5.00, MicroTech Medical (Hangzhou) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 808 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MicroTech Medical (Hangzhou) Co's current Piotroski F-Score of 6 is 20% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on MicroTech Medical (Hangzhou) Co and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MicroTech Medical (Hangzhou) Co's current Piotroski F-Score is 6, which is 50% above median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MicroTech Medical (Hangzhou) Co stock overvalued right now?
Based on GuruFocus' analysis, MicroTech Medical (Hangzhou) Co (HKSE:02235) is currently considered Possible Value Trap. The stock's GF Value™ is HK$15.94, compared to a current price of HK$7.26 — trading 54.5% below its estimated fair value. The current Piotroski F-Score is 6, which is 50% above median its 10-year median of 4.00 and 20% above the Medical Devices & Instruments industry median of 5.00. MicroTech Medical (Hangzhou) Co's overall GF Score™ is 80/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For MicroTech Medical (Hangzhou) Co (HKSE:02235), the current Piotroski F-Score is 6 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MicroTech Medical (Hangzhou) Co (HKSE:02235) Overvalued in 2026?
Based on GuruFocus' analysis, MicroTech Medical (Hangzhou) Co stock appears to be undervalued.
The current stock price of HK$7.26 is trading 54.5% below its estimated GF Value™ of HK$15.94.
GuruFocus considers MicroTech Medical (Hangzhou) Co to be Possible Value Trap.
Key valuation signals for HKSE:02235:
Piotroski F-Score: 6 (50% above median its 10-year median of 4.00)
GF Value™: HK$15.94 vs. price of HK$7.26 (54.5% below fair value)
Industry Position: 20% above the Medical Devices & Instruments median (#156 of 808)
No single metric tells the full story. See the HKSE:02235 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MicroTech Medical (Hangzhou) Co Ltd is focused on diabetes management, providing both diabetes treatment and diabetes monitoring medical devices to improve the diabetes management in China and globally. The Group operates in a large and fast-growing diabetes monitoring, treatment and management market in China and globally with unmet clinical needs. The company derives a majority of its revenue from China.
80GF Score
Get the complete analysis for HKSE:02235
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02235 has been successfully added to your 
